These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31287831)

  • 1. Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein.
    Ryser S; Tenorio E; Estellés A; Kauvar LM
    PLoS One; 2019; 14(7):e0219256. PubMed ID: 31287831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model.
    Estellés A; Woischnig AK; Liu K; Stephenson R; Lomongsod E; Nguyen D; Zhang J; Heidecker M; Yang Y; Simon RJ; Tenorio E; Ellsworth S; Leighton A; Ryser S; Gremmelmaier NK; Kauvar LM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2292-301. PubMed ID: 26833157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
    Xiong YQ; Estellés A; Li L; Abdelhady W; Gonzales R; Bayer AS; Tenorio E; Leighton A; Ryser S; Kauvar LM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics.
    Kurbatfinski N; Goodman SD; Bakaletz LO
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0187721. PubMed ID: 35007137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections.
    Novotny LA; Goodman SD; Bakaletz LO
    EBioMedicine; 2020 Sep; 59():102867. PubMed ID: 32651162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.
    Conway J; Delanois RE; Mont MA; Stavrakis A; McPherson E; Stolarski E; Incavo S; Oakes D; Salvagno R; Adams JS; Kisch-Hancock A; Tenorio E; Leighton A; Ryser S; Kauvar LM; Bernthal NM
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0065524. PubMed ID: 39012102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ; Bakaletz LO; Goodman SD
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo.
    Novotny LA; Jurcisek JA; Goodman SD; Bakaletz LO
    EBioMedicine; 2016 Aug; 10():33-44. PubMed ID: 27342872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics.
    Kurbatfinski N; Kramer CN; Goodman SD; Bakaletz LO
    Front Microbiol; 2023; 14():1202215. PubMed ID: 37564292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable
    Jurcisek JA; Hofer LK; Goodman SD; Bakaletz LO
    Biofilm; 2022 Dec; 4():100096. PubMed ID: 36532267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms.
    Brockson ME; Novotny LA; Mokrzan EM; Malhotra S; Jurcisek JA; Akbar R; Devaraj A; Goodman SD; Bakaletz LO
    Mol Microbiol; 2014 Sep; 93(6):1246-58. PubMed ID: 25069521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a Biofilm-Disrupting Nontypeable
    Bailey MT; Lauber CL; Novotny LA; Goodman SD; Bakaletz LO
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated Streptococcus pyogenes Infections.
    Freiberg JA; Le Breton Y; Harro JM; Allison DL; McIver KS; Shirtliff ME
    mBio; 2020 Jul; 11(4):. PubMed ID: 32636245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics.
    Rocco CJ; Davey ME; Bakaletz LO; Goodman SD
    Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins.
    Goodman SD; Obergfell KP; Jurcisek JA; Novotny LA; Downey JS; Ayala EA; Tjokro N; Li B; Justice SS; Bakaletz LO
    Mucosal Immunol; 2011 Nov; 4(6):625-37. PubMed ID: 21716265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms.
    Martyn L; Sethia R; Chon R; Novotny L; Goodman SD; Elmaraghy C; Bakaletz LO
    Laryngoscope; 2020 Jun; 130(6):1364-1371. PubMed ID: 31314141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Susceptibility of Escherichia coli Cells during Early-Stage Biofilm Formation.
    Gu H; Lee SW; Carnicelli J; Jiang Z; Ren D
    J Bacteriol; 2019 Sep; 201(18):. PubMed ID: 31061169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption.
    Ray VA; Hill PJ; Stover CK; Roy S; Sen CK; Yu L; Wozniak DJ; DiGiandomenico A
    Sci Rep; 2017 Nov; 7(1):16065. PubMed ID: 29167572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontypeable Haemophilus influenzae released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype.
    Wilbanks KQ; Mokrzan EM; Kesler TM; Kurbatfinski N; Goodman SD; Bakaletz LO
    Sci Rep; 2023 Aug; 13(1):12959. PubMed ID: 37563215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli.
    Tursi SA; Puligedda RD; Szabo P; Nicastro LK; Miller AL; Qiu C; Gallucci S; Relkin NR; Buttaro BA; Dessain SK; Tükel Ç
    Nat Commun; 2020 Feb; 11(1):1007. PubMed ID: 32081907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.